1. Academic Validation
  2. The discovery of sulfonamide endothelin antagonists and the development of the orally active ETA antagonist 5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulf onamide

The discovery of sulfonamide endothelin antagonists and the development of the orally active ETA antagonist 5-(dimethylamino)-N-(3,4-dimethyl-5-isoxazolyl)-1-naphthalenesulf onamide

  • J Med Chem. 1994 Feb 4;37(3):329-31. doi: 10.1021/jm00029a001.
P D Stein 1 J T Hunt D M Floyd S Moreland K E Dickinson C Mitchell E C Liu M L Webb N Murugesan J Dickey
Affiliations

Affiliation

  • 1 Department of Chemistry, Bristol-Myers Squibb Pharmaceutical Research Institute, Princeton, New Jersey 08543-4000.
Figures